Cell-free DNA screening for fetal aneuploidy as a clinical service.
暂无分享,去创建一个
[1] Cosmin Deciu,et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations , 2012, Prenatal diagnosis.
[2] S. Hauguel-de Mouzon,et al. A multifactorial relationship exists between total circulating cell‐free DNA levels and maternal BMI , 2012, Prenatal diagnosis.
[3] K. Nicolaides,et al. Prenatal Detection of Fetal Triploidy from Cell-Free DNA Testing in Maternal Blood , 2013, Fetal Diagnosis and Therapy.
[4] K. Nicolaides,et al. Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y , 2013, Prenatal diagnosis.
[5] Amin R. Mazloom,et al. Non-Invasive Prenatal Chromosomal Aneuploidy Testing - Clinical Experience: 100,000 Clinical Samples , 2014, PloS one.
[6] A. Siddiqui,et al. Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort , 2014, Obstetrics and gynecology.
[7] F. Grati. Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis , 2014, Journal of clinical medicine.
[8] I Xenarios,et al. A robust second‐generation genome‐wide test for fetal aneuploidy based on shotgun sequencing cell‐free DNA in maternal blood , 2013, Prenatal diagnosis.
[9] K. Nicolaides,et al. Fetal heart rate in chromosomally abnormal fetuses , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[10] K. Nicolaides,et al. Combined Screening for Preeclampsia and Small for Gestational Age at 11–13 Weeks , 2012, Fetal Diagnosis and Therapy.
[11] K. Spencer,et al. Age‐standardisation when target setting and auditing performance of Down syndrome screening programmes , 2004, Prenatal diagnosis.
[12] R. Rava,et al. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. , 2014, Clinical chemistry.
[13] T. Musci,et al. Clinical experience of noninvasive prenatal testing with cell‐free DNA for fetal trisomies 21, 18, and 13, in a general screening population , 2013, Prenatal diagnosis.
[14] H. C. Fan,et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.
[15] Gary J. W. Liao,et al. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing , 2014, Proceedings of the National Academy of Sciences.
[16] M. Norton,et al. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening , 2013, Prenatal diagnosis.
[17] Arnold Oliphant,et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.
[18] Peter Benn,et al. Prenatal Diagnosis of Chromosomal Abnormalities through Amniocentesis , 2010 .
[19] G. Shaw,et al. Risk of selected structural abnormalities in infants after increased nuchal translucency measurement. , 2014, American journal of obstetrics and gynecology.
[20] C. Comas,et al. Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[21] H. Cuckle,et al. Maternal cfDNA screening for Down syndrome – a cost sensitivity analysis , 2013, Prenatal diagnosis.
[22] K. Geršak,et al. Low-level X chromosome mosaicism in women with sporadic premature ovarian failure. , 2011, Reproductive biomedicine online.
[23] F. D’Antonio,et al. Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[24] Hui Jiang,et al. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X , 2012, Prenatal diagnosis.
[25] D. Wright,et al. First‐trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell‐free DNA testing , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[26] K. Nicolaides,et al. Performance of screening for aneuploidies by cell‐free DNA analysis of maternal blood in twin pregnancies , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[27] Matthew Rabinowitz,et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. , 2014, American journal of obstetrics and gynecology.
[28] C. Liao,et al. Discordant results between fetal karyotyping and non‐invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue , 2013, Prenatal diagnosis.
[29] S. Cheung,et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center , 2014 .
[30] Marilyn C. Jones,et al. Impact of Cell-Free Fetal DNA Screening on Patients’ Choice of Invasive Procedures after a Positive California Prenatal Screen Result , 2014, Journal of clinical medicine.
[31] D. Oepkes,et al. Summary of the ISPD Preconference Day, June 3, 2012, Miami Beach , 2013, Prenatal diagnosis.
[32] K. Nicolaides,et al. Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[33] Gary J. W. Liao,et al. Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing , 2013, Prenatal diagnosis.
[34] C. Cantor,et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.
[35] J. Canick,et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies , 2013, Prenatal diagnosis.
[36] H. Cuckle,et al. Non‐invasive prenatal testing for aneuploidy: current status and future prospects , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[37] B. Jacobsson,et al. European Non‐Invasive Trisomy Evaluation (EU‐NITE) study: a multicenter prospective cohort study for non‐invasive fetal trisomy 21 testing , 2013, Prenatal diagnosis.
[38] Y. Ville,et al. Combined screening for open spina bifida at 11-13 weeks using fetal biparietal diameter and maternal serum markers. , 2013, American journal of obstetrics and gynecology.
[39] Wade A. Barrett,et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy , 2012, Prenatal diagnosis.
[40] S. Papatheodorou,et al. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta‐analysis , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[41] Stephen R. Quake,et al. Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics , 2010, PloS one.
[42] Wei Wang,et al. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[43] Gary J. W. Liao,et al. Noninvasive prenatal determination of twin zygosity by maternal plasma DNA analysis. , 2013, Clinical chemistry.
[44] Lin Tang,et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.
[45] Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. , 2013, Obstetrics and gynecology.
[46] J. Dungan,et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011 .
[47] F. Grati,et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. , 2014, American journal of obstetrics and gynecology.
[48] G. Lambert-Messerlian,et al. Circulating cell free DNA testing: are some test failures informative? , 2015, Prenatal diagnosis.
[49] M. Rabinowitz,et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. , 2015, American journal of obstetrics and gynecology.
[50] G. Simoni,et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results , 2014, Genetics in Medicine.
[51] Argyro Syngelaki,et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.
[52] C. Strom,et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases , 2014, Genetics in Medicine.
[53] D. Liang,et al. Non‐invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing , 2013, Prenatal diagnosis.
[54] D. Cram,et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. , 2014, Clinical chemistry.
[55] P. Benn. Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects , 2014, Journal of clinical medicine.
[56] L. Dugoff,et al. Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 , 2012, Prenatal diagnosis.
[57] H. Meiri,et al. Economic assessment of screening for pre‐eclampsia , 2012, Prenatal diagnosis.
[58] A. Oliphant,et al. Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma , 2013, Prenatal diagnosis.
[59] D. Wright,et al. A unified approach to risk assessment for fetal aneuploidies , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[60] D. Horsman,et al. X chromosome aneuploidy in lymphocyte cultures from women with recurrent spontaneous abortions. , 1987, American journal of medical genetics.
[61] R. Wegner,et al. Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues with Vanishing Twins , 2014, Journal of clinical medicine.
[62] W. Meschino,et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell‐free DNA from maternal plasma , 2013, Prenatal diagnosis.
[63] Y. Gao,et al. Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[64] Yama W. L. Zheng,et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.
[65] NON-INVASIVE EXAMINATION OF PYRAMIDAL TRACT BY SPINAL EVOKED POTENTIALS , 1985, The Lancet.
[66] D. Weaver,et al. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism , 2013, Genetics in Medicine.
[67] K. Nicolaides,et al. Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[68] K. Choy,et al. Secondary findings from non‐invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service , 2013, Prenatal diagnosis.
[69] P. S. Ramsay,et al. Erratum: Clinical implementation of cell-free DNA-based aneuploidy screening: Perspectives from a national audit. (Ultrasound Obstet Gynecol (2015) 45, (10-15)) , 2015 .
[70] Kypros H. Nicolaides,et al. Noninvasive Prenatal Testing for Fetal Trisomies in a Routinely Screened First-Trimester Population , 2013 .
[71] Hanmin Lee,et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.
[72] M. Hempel,et al. Diagnostic accuracy of random massively parallel sequencing for non‐invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe , 2014, Prenatal diagnosis.
[73] K. Nicolaides,et al. Gestational sac volume measured by three‐dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[74] A. Siddiqui,et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. , 2015, American journal of obstetrics and gynecology.
[75] P. Jacobs. An opportune life: 50 years in human cytogenetics. , 2014, Annual review of genomics and human genetics.
[76] R. Rava,et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples , 2013, Prenatal diagnosis.
[77] E. Hardisty,et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease , 2013, Prenatal diagnosis.
[78] A. Cook,et al. Seasonal variation in fetal growth: accounting for sociodemographic, biological, and environmental exposures. , 2012, American journal of obstetrics and gynecology.
[79] H. Cuckle,et al. Theoretical performance of non‐invasive prenatal testing for chromosome imbalances using counting of cell‐free DNA fragments in maternal plasma , 2014, Prenatal diagnosis.
[80] H. Cuckle,et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. , 2012, Obstetrics and gynecology.
[81] Yijun Song,et al. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population , 2013, Prenatal diagnosis.
[82] F. Prefumo,et al. Accuracy of Ultrasonography at 11–14 Weeks of Gestation for Detection of Fetal Structural Anomalies: A Systematic Review , 2013, Obstetrics and gynecology.
[83] P. Jacobs,et al. X chromosome loss and ageing , 2007, Cytogenetic and Genome Research.
[84] E. Hardisty,et al. A single center’s experience with noninvasive prenatal testing , 2014, Genetics in Medicine.
[85] M. Evans,et al. Cell-free DNA: Comparison of Technologies. , 2016, Clinics in laboratory medicine.
[86] K. Nicolaides,et al. Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[87] Z. Alfirevic,et al. Update on Procedure-Related Risks for Prenatal Diagnosis Techniques , 2009, Fetal Diagnosis and Therapy.
[88] Matthew Rabinowitz,et al. Non-invasive prenatal aneuploidy testing at chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci , 2013 .
[89] H. Cuckle,et al. Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects , 2015, Genetic Disorders and the Fetus.
[90] Tianhua Huang,et al. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy‐associated plasma protein A, free‐β human chorionic gonadotrophin, placental growth factor, and α‐fetoprotein , 2015, Prenatal diagnosis.
[91] Wei Wang,et al. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience , 2014, Prenatal diagnosis.
[92] C F A Peralta,et al. Placental volume measured by three‐dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[93] Jian Wang,et al. Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors , 2012, Prenatal diagnosis.
[94] K. Nicolaides,et al. Cell-Free DNA Analysis for Trisomy Risk Assessment in First-Trimester Twin Pregnancies , 2013, Fetal Diagnosis and Therapy.
[95] J. T. Lumeij,et al. Avian Clinical Biochemistry , 1997 .
[96] Stanley F. Nelson,et al. Dna Sequencing of Maternal Plasma to Detect Down Syndrome: An International Clinical Validation Study , 2012 .
[97] R. Rava,et al. 52: Maternal plasma DNA sequencing: effects of multiple gestation on aneuploidy detection and the relative cell-free fetal DNA (cffDNA) per fetus , 2012 .
[98] D. Cram,et al. Two cases of placental T21 mosaicism: challenging the detection limits of non‐invasive prenatal testing , 2013, Prenatal diagnosis.
[99] Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss , 2014, Human Genetics.
[100] M. Lutgendorf,et al. Noninvasive prenatal testing: limitations and unanswered questions , 2013, Genetics in Medicine.
[101] Hui Jiang,et al. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies , 2014, Prenatal diagnosis.
[102] K. Nicolaides,et al. Prevention of Perinatal Death and Adverse Perinatal Outcome Using Low-Dose Aspirin: A Meta-Analysis , 2013 .
[103] Aubrey Milunsky,et al. Genetic Disorders and the Fetus: "Diagnosis, Prevention, And Treatment" , 2012 .
[104] Kypros H. Nicolaides,et al. Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers , 2012, Fetal Diagnosis and Therapy.
[105] A. Luciano,et al. 45,X/46,XX mosaicism in patients with idiopathic premature ovarian failure. , 1998, Fertility and sterility.
[106] K. Nicolaides,et al. Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks , 2011, Prenatal diagnosis.